English

HEMOBIOTECH, INC.

EDGAR

Annual report (10-K) · filed 2010-05-27

25 filing records in this dataset, filed from 2005-06-24 to 2010-05-27. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2009-12-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

8.42 million USD

2009-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -1028000 USD Source
Operating Cash Flow: -9448000 USD Source

Cash and cash equivalents: 55 thousand USD 2009-12-31 Source
Exact value

55000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

59 thousand USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Capital expenditure: 0 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 59000 USD · 2009-01-01 – 2009-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-05-27.

Financial data available through: 2009-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2009-12-31
operating income: No compatible figures in this window
Net income: 6 of 11 periods available· newest 2009-12-31
Operating cash flow: 6 of 11 periods available· newest 2009-12-31
Capital expenditure: 6 of 11 periods available· newest 2009-12-31
Total assets: 4 of 11 periods available· newest 2009-12-31
Total liabilities: 3 of 11 periods available· newest 2009-12-31
Current assets: 5 of 11 periods available· newest 2009-12-31
Current liabilities: 5 of 11 periods available· newest 2009-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2009-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2008-01-01 – 2008-12-31
Current period

USD 0

2009-01-01 – 2009-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
0 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · HEMOBIOTECH, INC. · 2009-12-31 HEMOBIOTECH, INC. (edgar:1301348) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#10754 Input fundies:Revenue: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#10754
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 1.49 million

Prior period

−USD 3.83 million

2008-01-01 – 2008-12-31
Current period

−USD 2.34 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

-2339000 − -3832000 = 1493000 USD

-3832000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-2339000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · HEMOBIOTECH, INC. · 2009-12-31 HEMOBIOTECH, INC. (edgar:1301348) Year-over-year change in Net income: 1493000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2339000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17456 Input fundies:NetIncome: -3832000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17456
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 956,000

Prior period

−USD 1.98 million

2008-01-01 – 2008-12-31
Current period

−USD 1.03 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

-1028000 − -1984000 = 956000 USD

-1984000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
-1028000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · HEMOBIOTECH, INC. · 2009-12-31 HEMOBIOTECH, INC. (edgar:1301348) Year-over-year change in Operating cash flow: 956000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1028000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17744 Input fundies:OperatingCashFlow: -1984000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17744
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
USD 0

Prior period

USD 0

2008-01-01 – 2008-12-31
Current period

USD 0

2009-01-01 – 2009-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
0 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · HEMOBIOTECH, INC. · 2009-12-31 HEMOBIOTECH, INC. (edgar:1301348) Year-over-year change in Capital expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17814 Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17814
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2009-01-01 – 2009-12-31

Revenue USD 0
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 2.34 million

Cash

Operating cash flow −USD 1.03 million
Capital expenditure USD 0
Free cash flow Derived −USD 1.03 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Not shown: operating income or net income is not reported.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.
2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2005-01-01 – 2005-12-31	Unavailable	Unavailable	Unavailable	-3454000	-1455000 Derived	Source 2005-01-01 – 2005-12-31: 0 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -3454000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -1445000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 10000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	Unavailable	Unavailable	Unavailable	-2571000	-2143000 Derived	Source 2006-01-01 – 2006-12-31: 0 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -2571000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -2140000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 3000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	Unavailable	Unavailable	Unavailable	-3725000	-2809000 Derived	Source 2007-01-01 – 2007-12-31: 0 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -3725000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -2766000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 43000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	Unavailable	Unavailable	Unavailable	-3832000	-1984000 Derived	Source 2008-01-01 – 2008-12-31: 0 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -3832000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -1984000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 0 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	Unavailable	Unavailable	Unavailable	-2339000	-1028000 Derived	Source 2009-01-01 – 2009-12-31: 0 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -2339000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -1028000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2009

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
20052005-12-31	Revenue	Revenue: 0 Open source
20062006-12-31	Revenue	Revenue: 0 Open source
20072007-12-31	Revenue	Revenue: 0 Open source
20082008-12-31	Revenue	Revenue: 0 Open source
20092009-12-31	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20062006-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20072007-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20082008-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Operating margin	Not reported	Revenue: 0 Open source
2006-12-31	Operating margin	Not reported	Revenue: 0 Open source
2007-12-31	Operating margin	Not reported	Revenue: 0 Open source
2008-12-31	Operating margin	Not reported	Revenue: 0 Open source
2009-12-31	Operating margin	Not reported	Revenue: 0 Open source
20052005-12-31	Net margin	Not reported	Net Income: -3454000 Open source Revenue: 0 Open source
20062006-12-31	Net margin	Not reported	Net Income: -2571000 Open source Revenue: 0 Open source
20072007-12-31	Net margin	Not reported	Net Income: -3725000 Open source Revenue: 0 Open source
20082008-12-31	Net margin	Not reported	Net Income: -3832000 Open source Revenue: 0 Open source
20092009-12-31	Net margin	Not reported	Net Income: -2339000 Open source Revenue: 0 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1445000 Open source Capital Expenditure: 10000 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2140000 Open source Capital Expenditure: 3000 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2766000 Open source Capital Expenditure: 43000 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1984000 Open source Capital Expenditure: 0 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1028000 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1M 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Operating cash flow	-1445000	Operating Cash Flow: -1445000 Open source
20062006-12-31	Operating cash flow	-2140000	Operating Cash Flow: -2140000 Open source
20072007-12-31	Operating cash flow	-2766000	Operating Cash Flow: -2766000 Open source
20082008-12-31	Operating cash flow	-1984000	Operating Cash Flow: -1984000 Open source
20092009-12-31	Operating cash flow	-1028000	Operating Cash Flow: -1028000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1M 2009

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Free cash flow	-1455000	Operating Cash Flow: -1445000 Open source Capital Expenditure: 10000 Open source
20062006-12-31	Free cash flow	-2143000	Operating Cash Flow: -2140000 Open source Capital Expenditure: 3000 Open source
20072007-12-31	Free cash flow	-2809000	Operating Cash Flow: -2766000 Open source Capital Expenditure: 43000 Open source
20082008-12-31	Free cash flow	-1984000	Operating Cash Flow: -1984000 Open source Capital Expenditure: 0 Open source
20092009-12-31	Free cash flow	-1028000	Operating Cash Flow: -1028000 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

383.5% 2009

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Liabilities / assets	Not reported	No source recorded
2006-12-31	Liabilities / assets	Not reported	Total Assets: 4259000 Open source
20072007-12-31	Liabilities / assets	11.2%	Total Liabilities: 297000 Open source Total Assets: 2641000 Open source
20082008-12-31	Liabilities / assets	71.3%	Total Liabilities: 576000 Open source Total Assets: 808000 Open source
20092009-12-31	Liabilities / assets	383.5%	Total Liabilities: 836000 Open source Total Assets: 218000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.17× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Current assets / current liabilities	1.81×	Current Assets: 1301000 Open source Current Liabilities: 717000 Open source
20062006-12-31	Current assets / current liabilities	24.84×	Current Assets: 4247000 Open source Current Liabilities: 171000 Open source
20072007-12-31	Current assets / current liabilities	9.98×	Current Assets: 2536000 Open source Current Liabilities: 254000 Open source
20082008-12-31	Current assets / current liabilities	1.32×	Current Assets: 712000 Open source Current Liabilities: 538000 Open source
20092009-12-31	Current assets / current liabilities	0.17×	Current Assets: 138000 Open source Current Liabilities: 799000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2004 2004-01-01 – 2004-12-31	−USD 1.26 million Exact value Exact value: -1259000 USD 2004-01-01 – 2004-12-31: -1259000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMOBIOTECH, INC. · 2004-12-31 HEMOBIOTECH, INC. (edgar:1301348) Net Income: -1259000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1259000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0000930413-06-002524.txt#2787 The citation records this snapshot. The page link may show a newer release later.	−USD 429,000 Exact value Exact value: -429000 USD 2004-01-01 – 2004-12-31: -429000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMOBIOTECH, INC. · 2004-12-31 HEMOBIOTECH, INC. (edgar:1301348) Operating Cash Flow: -429000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -429000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0000930413-06-002524.txt#2805 The citation records this snapshot. The page link may show a newer release later.	USD 3,000 Exact value Exact value: 3000 USD 2004-01-01 – 2004-12-31: 3000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HEMOBIOTECH, INC. · 2004-12-31 HEMOBIOTECH, INC. (edgar:1301348) Capital Expenditure: 3000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0000930413-06-002524.txt#2808 The citation records this snapshot. The page link may show a newer release later.	−USD 432,000 Calculation and evidence -429000 − 3000 USD Exact free cash flow: -432000 USD 2004-01-01 – 2004-12-31: -429000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 3000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HEMOBIOTECH, INC. · 2004-12-31 HEMOBIOTECH, INC. (edgar:1301348) Free cash flow: -432000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -429000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0000930413-06-002524.txt#2805 Input fundies:CapitalExpenditure: 3000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0000930413-06-002524.txt#2808 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 3.45 million Exact value Exact value: -3454000 USD 2005-01-01 – 2005-12-31: -3454000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMOBIOTECH, INC. · 2005-12-31 HEMOBIOTECH, INC. (edgar:1301348) Net Income: -3454000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3454000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-07-000035.txt#9208 The citation records this snapshot. The page link may show a newer release later.	−USD 1.45 million Exact value Exact value: -1445000 USD 2005-01-01 – 2005-12-31: -1445000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMOBIOTECH, INC. · 2005-12-31 HEMOBIOTECH, INC. (edgar:1301348) Operating Cash Flow: -1445000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1445000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-07-000035.txt#9526 The citation records this snapshot. The page link may show a newer release later.	USD 10,000 Exact value Exact value: 10000 USD 2005-01-01 – 2005-12-31: 10000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HEMOBIOTECH, INC. · 2005-12-31 HEMOBIOTECH, INC. (edgar:1301348) Capital Expenditure: 10000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-07-000035.txt#9604 The citation records this snapshot. The page link may show a newer release later.	−USD 1.46 million Calculation and evidence -1445000 − 10000 USD Exact free cash flow: -1455000 USD 2005-01-01 – 2005-12-31: -1445000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 10000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HEMOBIOTECH, INC. · 2005-12-31 HEMOBIOTECH, INC. (edgar:1301348) Free cash flow: -1455000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1445000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-07-000035.txt#9526 Input fundies:CapitalExpenditure: 10000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-07-000035.txt#9604 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 2.57 million Exact value Exact value: -2571000 USD 2006-01-01 – 2006-12-31: -2571000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMOBIOTECH, INC. · 2006-12-31 HEMOBIOTECH, INC. (edgar:1301348) Net Income: -2571000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2571000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-08-000003.txt#9401 The citation records this snapshot. The page link may show a newer release later.	−USD 2.14 million Exact value Exact value: -2140000 USD 2006-01-01 – 2006-12-31: -2140000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMOBIOTECH, INC. · 2006-12-31 HEMOBIOTECH, INC. (edgar:1301348) Operating Cash Flow: -2140000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2140000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-08-000003.txt#9672 The citation records this snapshot. The page link may show a newer release later.	USD 3,000 Exact value Exact value: 3000 USD 2006-01-01 – 2006-12-31: 3000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HEMOBIOTECH, INC. · 2006-12-31 HEMOBIOTECH, INC. (edgar:1301348) Capital Expenditure: 3000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-08-000003.txt#9726 The citation records this snapshot. The page link may show a newer release later.	−USD 2.14 million Calculation and evidence -2140000 − 3000 USD Exact free cash flow: -2143000 USD 2006-01-01 – 2006-12-31: -2140000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 3000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HEMOBIOTECH, INC. · 2006-12-31 HEMOBIOTECH, INC. (edgar:1301348) Free cash flow: -2143000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2140000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-08-000003.txt#9672 Input fundies:CapitalExpenditure: 3000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-08-000003.txt#9726 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 3.73 million Exact value Exact value: -3725000 USD 2007-01-01 – 2007-12-31: -3725000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMOBIOTECH, INC. · 2007-12-31 HEMOBIOTECH, INC. (edgar:1301348) Net Income: -3725000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3725000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-09-000013.txt#7915 The citation records this snapshot. The page link may show a newer release later.	−USD 2.77 million Exact value Exact value: -2766000 USD 2007-01-01 – 2007-12-31: -2766000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMOBIOTECH, INC. · 2007-12-31 HEMOBIOTECH, INC. (edgar:1301348) Operating Cash Flow: -2766000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2766000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-08-000003.txt#9672 The citation records this snapshot. The page link may show a newer release later.	USD 43,000 Exact value Exact value: 43000 USD 2007-01-01 – 2007-12-31: 43000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HEMOBIOTECH, INC. · 2007-12-31 HEMOBIOTECH, INC. (edgar:1301348) Capital Expenditure: 43000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 43000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-08-000003.txt#9726 The citation records this snapshot. The page link may show a newer release later.	−USD 2.81 million Calculation and evidence -2766000 − 43000 USD Exact free cash flow: -2809000 USD 2007-01-01 – 2007-12-31: -2766000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 43000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HEMOBIOTECH, INC. · 2007-12-31 HEMOBIOTECH, INC. (edgar:1301348) Free cash flow: -2809000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2766000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-08-000003.txt#9672 Input fundies:CapitalExpenditure: 43000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001301348-08-000003.txt#9726 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 3.83 million Exact value Exact value: -3832000 USD 2008-01-01 – 2008-12-31: -3832000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMOBIOTECH, INC. · 2008-12-31 HEMOBIOTECH, INC. (edgar:1301348) Net Income: -3832000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3832000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17456 The citation records this snapshot. The page link may show a newer release later.	−USD 1.98 million Exact value Exact value: -1984000 USD 2008-01-01 – 2008-12-31: -1984000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMOBIOTECH, INC. · 2008-12-31 HEMOBIOTECH, INC. (edgar:1301348) Operating Cash Flow: -1984000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1984000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17744 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2008-01-01 – 2008-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HEMOBIOTECH, INC. · 2008-12-31 HEMOBIOTECH, INC. (edgar:1301348) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17814 The citation records this snapshot. The page link may show a newer release later.	−USD 1.98 million Calculation and evidence -1984000 − 0 USD Exact free cash flow: -1984000 USD 2008-01-01 – 2008-12-31: -1984000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HEMOBIOTECH, INC. · 2008-12-31 HEMOBIOTECH, INC. (edgar:1301348) Free cash flow: -1984000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1984000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17744 Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17814 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 2.34 million Exact value Exact value: -2339000 USD 2009-01-01 – 2009-12-31: -2339000 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMOBIOTECH, INC. · 2009-12-31 HEMOBIOTECH, INC. (edgar:1301348) Net Income: -2339000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2339000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17456 The citation records this snapshot. The page link may show a newer release later.	−USD 1.03 million Exact value Exact value: -1028000 USD 2009-01-01 – 2009-12-31: -1028000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMOBIOTECH, INC. · 2009-12-31 HEMOBIOTECH, INC. (edgar:1301348) Operating Cash Flow: -1028000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1028000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17744 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · HEMOBIOTECH, INC. · 2009-12-31 HEMOBIOTECH, INC. (edgar:1301348) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17814 The citation records this snapshot. The page link may show a newer release later.	−USD 1.03 million Calculation and evidence -1028000 − 0 USD Exact free cash flow: -1028000 USD 2009-01-01 – 2009-12-31: -1028000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · HEMOBIOTECH, INC. · 2009-12-31 HEMOBIOTECH, INC. (edgar:1301348) Free cash flow: -1028000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/1301348?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1028000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17744 Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1301348/0001144204-10-030736.txt#17814 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

25 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001301348, 1301348, edgar:1301348

Also known as HEMOBIOTECH INC

HEMOBIOTECH, INC.

Latest quarter

Revenue

Operating cash flow

Trailing twelve months

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2009 2009-01-01 – 2009-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation